catechin has been researched along with fluconazole in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 9 (90.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
El-Gohary, NS; Shaaban, MI | 4 |
Abdel-Rahman, SA; El-Ashry, SM; El-Bendary, ER; El-Gohary, NS; Shaaban, MI | 1 |
Jin, YS | 1 |
Fukushima, K; Hyon, SH; Park, BJ; Park, JC; Taguchi, H; Takatori, K | 1 |
Cavalcanti, BC; da Silva, CR; de Andrade Neto, JB; de Andrade, GM; de Barros Viana, GS; de Moraes, MO; de Sousa Campos, R; Figueiredo, NS; Gaspar, DM; Grangeiro, TB; Lima, IS; Lobo, MD; Magalhães, HI; Nobre Júnior, HV; Sampaio, LS | 1 |
Ling, J; Ning, Y; Wu, CD | 1 |
1 review(s) available for catechin and fluconazole
Article | Year |
---|---|
Recent advances in natural antifungal flavonoids and their derivatives.
Topics: Antifungal Agents; Biological Products; Flavonoids; Fungi; Humans; Mycoses | 2019 |
9 other study(ies) available for catechin and fluconazole
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis and biological evaluation of a new series of benzimidazole derivatives as antimicrobial, antiquorum-sensing and antitumor agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fungi; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
Synthesis, antimicrobial, antiquorum-sensing and antitumor activities of new benzimidazole analogs.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Aspergillus fumigatus; Bacillus cereus; Benzimidazoles; Candida albicans; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Quorum Sensing; Staphylococcus aureus; Structure-Activity Relationship | 2017 |
Synthesis, antimicrobial, antiquorum-sensing, antitumor and cytotoxic activities of new series of cyclopenta(hepta)[b]thiophene and fused cyclohepta[b]thiophene analogs.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Cell Line; Cell Proliferation; Cycloheptanes; Cyclopentanes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fungi; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship; Thiophenes | 2017 |
New pyrazolopyridine analogs: Synthesis, antimicrobial, antiquorum-sensing and antitumor screening.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fungi; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Pyridines; Structure-Activity Relationship | 2018 |
Design, synthesis, antimicrobial, antiquorum-sensing and antitumor evaluation of new series of pyrazolopyridine derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Aspergillus flavus; Aspergillus fumigatus; Bacillus cereus; Candida albicans; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Pseudomonas aeruginosa; Pyrazoles; Pyridines; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catechin; Dose-Response Relationship, Drug; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Species Specificity | 2006 |
Synergistic effect of the flavonoid catechin, quercetin, or epigallocatechin gallate with fluconazole induces apoptosis in Candida tropicalis resistant to fluconazole.
Topics: Antifungal Agents; Apoptosis; Candida tropicalis; Catechin; Drug Interactions; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Microbial Sensitivity Tests; Quercetin; Reactive Oxygen Species | 2014 |
Synergistic effects of tea catechin epigallocatechin gallate and antimycotics against oral Candida species.
Topics: Amphotericin B; Anilides; Antifungal Agents; Biofilms; Candida; Catechin; Drug Synergism; Fluconazole; Miconazole; Microbial Sensitivity Tests; Polyphenols; Tetrazolium Salts | 2015 |